FDA Wants Feedback On How To Properly Label Devices With Risky Materials

The US agency wants stakeholders to chime in on what information should be included in product labels to notify patients about potential side-effects of medical device materials, without being too burdensome for manufacturers.

Entrance to FDA headquarters in Maryland

More from Regulation

More from Policy & Regulation